Tuesday broker round-up
11th May 2021 13:31
(Sharecast News) - Safestore: Liberum upgrades to buy with a target price of 1,060p.
Read moreSunday newspaper round-up: GlaxoSmithKline, Rare Earths, Amazon
2nd May 2021 12:32
(Sharecast News) - Top investors in Glaxo Smith Kline are piling pressure on Dame Emma Walmsley after the activist New York hedge fund Elliott Management was revealed to have built a significant stake. Two top-20 investors in the drugs and consumer goods giant said that the chief executive's future was in doubt after four years of disappointing performance. One top-20 investor said there was "no desire to protect her" among institutional shareholders. Another said that Walmsley, 51, should step aside after her plan to break the business in two is carried out and hand over to her lieutenant, Luke Miels. - Sunday Times
Read moreGSK sticks to guidance after crisis hits profit and revenue
28th Apr 2021 12:23
(Sharecast News) - GlaxoSmithKline stuck to its annual guidance after the Covid-19 crisis caused profit and revenue to fall in the first quarter of 2021.
Read moreLondon midday: Stocks dip despite barrage of positive readings on the economy
23rd Apr 2021 12:04
(Sharecast News) - Stocks are holding lower at the end of the week despite very positive news out on the UK economy, after Bloomberg reported that Democrats on Capitol Hill want to double the US capital gains tax to nearly 39.6%.
Read moreGlaxoSmithKline gets US FDA approval for 'Jemperli'
23rd Apr 2021 07:15
(Sharecast News) - GlaxoSmithKline announced on Friday that the US Food and Drug Administration (FDA) has approved 'Jemperli', or dostarlimab-gxly, based on its Biologics License Application.
Read moreGlaxo shares rally as Elliott said to have built 'significant' stake
15th Apr 2021 12:33
(Sharecast News) - GlaxoSmithKline shares shot higher on Thursday as it emerged that activist hedge fund Elliott Management has built a multibillion-pound stake in the pharmaceuticals company.
Read moreGlaxo fires former Trump vaccine tsar over harassment allegations
24th Mar 2021 14:45
(Sharecast News) - GlaxoSmithKline said on Wednesday that it has fired Moncef Slaoui as chair of the board of directors of Galvani, in which it owns a majority stake, amid allegations of sexual harassment.
Read moreTuesday broker round-up
23rd Mar 2021 13:12
(Sharecast News) - Fevertree: Barclays upgrades to buy with a target price of 2,500p.
Read moreSunday share tips: BBGI, GlaxoSmithKline
21st Mar 2021 12:53
(Sharecast News) - The Financial Mail on Sunday's Midas column recommended shares of BBGI to its readers, calling attention to management's good track record and the firm's "rich" pipeline of potential investments.
Read moreGlaxoSmithKline and Medicago start Phase 3 clinical testing on plant-derived Covid-19 vaccine candidate
16th Mar 2021 13:07
(Sharecast News) - Pharmaceutical giant GlaxoSmithKline said on Tuesday that it has started Phase 3 clinical testing of Medicago's plant-derived Covid-19 vaccine candidate in combination with its own pandemic adjuvant.
Read moreTalks between Hikma and GlaxoSmithKline fail to secure a deal
11th Mar 2021 13:50
(Sharecast News) - Talks between Hikma Pharmaceutical and drugs giant GlaxoSmithKline have ended, the generics group confirmed on Thursday.
Read moreGlaxo, Vir stop Covid trial early after drug shows 85% efficacy
11th Mar 2021 08:17
(Sharecast News) - Drug companies GlaxoSmithKline and Vir Biotechnology have been advised to finish a final trial of their Covid-19 drug early due to its "profound efficacy".
Read moreThursday broker round-up
4th Mar 2021 13:25
(Sharecast News) - Weir: Deutsche Bank downgrades to hold with a target price of 2,000p.
Read moreGSK Covid-19 monoclonal treatment shows potential benefit for older patients
25th Feb 2021 19:21
(Sharecast News) - A phase two clinical study on GlaxoSmithKline's monoclonal antibody treatment against Covid-19 revealed a "potentially important" benefit in reducing respiratory failure in patients aged 70 or older.
Read moreGSK and Sanofi start phase 2 trial on refined Covid-19 vaccine
22nd Feb 2021 11:05
(Sharecast News) - GlaxoSmithKline and Sanofi have started a new clinical trial into their Cobid-19 vaccine candidate with the aim of refining the dosage.
Read more